G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells

FEBS Letters

Volumn 461, Issue 3, 1999, Pages 299-305

  Siu, Wai Yi ^a   Yam, Cain H ^a   Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

CDK; Cell cycle control; Cyclin; DNA damage; p53

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CDC2 PROTEIN KINASE; CELL DIVISION; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DOXORUBICIN; G0 PHASE; G1 PHASE; G2 PHASE; GENE EXPRESSION REGULATION; GENES, P53; MICE; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 0032717265     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01481-7     Document Type: Article

References (30)

1. King R.W., Jackson P.K., Kirschner M.W. Cell. 79:1994;563-571.
2. Sherr C.J. Cell. 79:1994;551-555.
3. Heichman K.A., Roberts J.M. Cell. 79:1994;557-562.
4. Poon, R.Y.C. (1996) in: Encyclopedia of Cancer (Bertino, J.R., Ed.), pp. 246-255, Academic Press, San Diego.
5. Morgan D.O. Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
6. Poon R.Y.C., Hunter T. Science. 270:1995;90-93.
7. Harper J.W. Cancer Surv. 29:1997;91-107.
8. Hartwell L.H., Weinert T.A. Science. 246:1989;629-634.
9. Elledge S.J. Science. 274:1996;1664-1671.
10. Di Leonardo A., Linke S.P., Clarkin K., Wahl G.M. Genes Dev. 8:1994;2540-2541.
11. Liebermann D.A., Hoffman B., Steinman R.A. Oncogene. 11:1995;199-210.
12. O'Connor P.M. Cancer Surv. 29:1997;151-182.
13. Levin A.J. Cell. 88:1997;323-331.
14. Kastan M.B. Bioessays. 18:1996;617-619.
15. Prives C. Cell. 95:1998;5-8.
16. Brugarolas J., Chandrasekaran C., Gordon J.I., Beach D., Jacks T., Hannon G.J. Nature. 377:1995;552-557.
17. Deng C., Zhang P., Harper J.W., Elledge S.J., Leder P. Cell. 82:1995;675-684.
18. Levedakou E.N., Kaufmann W.K., Alcorta D.A., Galloway D.A., Paules R.S. Cancer Res. 55:1995;2500-2502.
19. Poon R.Y.C., Jiang W., Toyoshima H., Hunter T. J. Biol. Chem. 271:1996;13283-13291.
20. Poon R.Y.C., Chau M.S., Yamashita K., Hunter T. Cancer Res. 57:1997;5168-5178.
21. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. Science. 277:1997;1501-1505.
22. Furnari B., Rhind N., Russell P. Science. 277:1997;1495-1497.
23. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu Z., Piwnica-Worms H., Elledge S.J. Science. 277:1997;1497-1501.
24. Poon R.Y.C., Toyoshima H., Hunter T. Mol. Biol. Cell. 6:1995;1197-1213.
25. Siu W.Y., Arooz T., Poon R.Y.C. Exp. Cell Res. 250:1999;131-141.
26. Kobayashi H., Golsteyn R., Poon R., Stewart E., Gannon J., Minshull J., Smith R., Hunt T. Cold Spring Harb. Symp. Quant. Biol. 56:1991;437-447.
27. Yam C.H., Ng R.W.M., Siu W.Y., Lau A.W.S., Poon R.Y.C. Mol. Cell. Biol. 19:1999;635-645.
28. Osheroff N., Corbett A.H., Robinson M.J. Adv. Pharmacol. 29:1994;105-126.
29. Keizer H.G., Pinedo H.M., Schuurhuis G.J., Joenje H. Pharmacol. Ther. 47:1990;219-231.
30. Dou Q.P., Levin A.H., Zhao S., Pardee A.B. Cancer Res. 53:1993;1493-1497.